Page last updated: 2024-10-21

2,2'-azobis(2-amidinopropane) and Anemia, Sickle Cell

2,2'-azobis(2-amidinopropane) has been researched along with Anemia, Sickle Cell in 2 studies

2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tatum, VL2
Chow, CK2
Natta, CL1

Other Studies

2 other studies available for 2,2'-azobis(2-amidinopropane) and Anemia, Sickle Cell

ArticleYear
Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress.
    Free radical research, 1996, Volume: 25, Issue:2

    Topics: Adult; Amidines; Anemia, Sickle Cell; Antioxidants; Erythrocytes, Abnormal; Female; Hemolysis; Human

1996
Antioxidant status and free radical-induced oxidative damage of sickle erythrocytes.
    Annals of the New York Academy of Sciences, 1992, Sep-30, Volume: 669

    Topics: Amidines; Anemia, Sickle Cell; Antioxidants; Carotenoids; Erythrocytes; Free Radicals; Glutathione;

1992